Journal
NATURE STRUCTURAL & MOLECULAR BIOLOGY
Volume 29, Issue 11, Pages 1040-1042Publisher
NATURE PORTFOLIO
DOI: 10.1038/s41594-022-00858-9
Keywords
-
Funding
- US National Institutes of Health [5T32GM133351, R01 CA228211]
- Pew-Stewart Scholars for Cancer Research
- American Cancer Society Research Scholar Award
Ask authors/readers for more resources
Recent research reveals that the CoREST complex plays a crucial role in regulating the acquisition of endocrine therapy resistance in estrogen receptor-positive breast cancers. Profiling data demonstrate that this resistance transition is associated with the functional retargeting of CoREST on chromatin, which occurs in coordination with cJUN and SWI/SNF (cBAF).
New research shows that the CoREST complex controls the acquisition of endocrine therapy resistance in estrogen receptor-positive breast cancers. Profiling data show that this resistance transition is accompanied by a functional retargeting of CoREST on chromatin in coordination with cJUN and SWI/SNF (cBAF).
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
